We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Merck Millipore Introduces Novel Clarisolve® Depth Filters

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Merck Millipore have introduced the Clarisolve® depth filter for single-stage clarification of pretreated feed streams. The Clarisolve® depth filter is a novel clarification device with a gradient density structure specifically designed to the particle size distributions of pretreated feed streams. 

Delivering improved volumetric capacity and reduced turbidity over any currently available depth filtration technologies, Clarisolve® depth filters process pretreated feeds in a significantly reduced footprint without the need for the secondary stage of clarification. The use of Clarisolve® depth filters eliminates the need for centrifugation which enables implementation of a fully single-use process train, and also considerably reduces the pre-use flushing requirements.  This technology was developed to address the shortcomings of traditional downstream clarification approaches when processing high cell density and high-product titer cell cultures.   

”Until now, higher titers coming from upstream bioreactors have posed a challenge to conventional approaches to clarification,” described Vin Donovan, Vice President of Biopharm Process Solutions, Merck Millipore.  “With Clarisolve® depth filters, our customers can now take full advantage of high density pre-treated feed streams and improve overall process economics. 

Clarisolve® filters are available from lab, to pilot, to process scale in the industry leading disposable Pod format.